| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang LY, Harris VA, Long RS, Liang XP, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen MC, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA NATURE 415 (6869): 331-335 JAN 17 2002 and the citing papers |
Nodes: 184
Authors: 955,
Journals: 64,
Outer References: 6346
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 29 | 1 2002 AIDS 16():S85-S88
Wahren B; Landay A HIV immunology better understood and vaccination attempts started | 0 | 0 |
| 2 | 3 | 103 | 2 2002 AIDS 16():S115-S124
O'Hagan DT; Lavelle E Novel adjuvants and delivery systems for HIV vaccines | 0 | 2 |
| 3 | 2 | 63 | 3 2002 BIOFUTUR (226):52-58
Allen TM; Kelleher AD; Zaunders J; Walker BD Structured treatment interruption and beyond | 0 | 0 |
| 4 | 1 | 124 | 4 2002 BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 19 19():205-242
Baumeister MA; Chattergoon MA; Weiner DB Prospects for an HIV vaccine: Conventional approaches and DNA immunization | 0 | 0 |
| 5 | 2 | 41 | 5 2002 BRITISH MEDICAL BULLETIN 62():87-98
McMichael A; Mwau M; Hanke T Design and tests of an HIV vaccine | 2 | 4 |
| 6 | 3 | 11 | 6 2002 CELL 110(2):135-138
Ho DD; Huang YX The HIV-1 vaccine race | 1 | 15 |
| 7 | 3 | 162 | 7 2002 CLINICS IN LABORATORY MEDICINE 22(3):773-+
Piazza P; Fan Z; Rinaldo CR CD8+T-cell immunity to HIV infection | 0 | 0 |
| 8 | 1 | 54 | 8 2002 CLINICS IN LABORATORY MEDICINE 22(4):963-+
Elizaga ML; McElrath MJ Progress in the development of a preventive HIV-1 vaccine | 0 | 0 |
| 9 | 3 | 69 | 9 2002 CURRENT OPINION IN IMMUNOLOGY 14(4):487-494
Gandhi RT; Walker BD Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection | 0 | 4 |
| 10 | 3 | 60 | 10 2002 CURRENT OPINION IN MOLECULAR THERAPEUTICS 4(5):459-466
Payne LG; Fuller DH; Haynes JR Particle-mediated DNA vaccination of mice, monkeys and men: Looking beyond the dogma | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 11 | 2 | 6 | 11 2002 DNA AND CELL BIOLOGY 21(9):597-598
Robert-Guroff M HIV regulatory and accessory proteins: New targets for vaccine development | 0 | 0 |
| 12 | 1 | 19 | 12 2002 DNA AND CELL BIOLOGY 21(9):653-658
Verrier B; Le Grand R; Ataman-Onal Y; Terrat C; Guillon C; Durand PY; Hurtrel B; Aubertin AM; Sutter G; Erfle V; Girard M Evaluation in rhesus macaques of Tat and Rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08 | 1 | 5 |
| 13 | 3 | 41 | 13 2002 DNA AND CELL BIOLOGY 21(9):671-678
Addo MM; Yu XG; Rosenberg ES; Walker BD; Altfeld M Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection | 0 | 2 |
| 14 | 2 | 35 | 14 2002 DNA AND CELL BIOLOGY 21(9):689-695
Muthumani K; Hwang DS; Dayes NS; Kim JJ; Weiner DB The HIV-1 accessory gene vpr can inhibit antigen-specific immune function | 0 | 2 |
| 15 | 1 | 279 | 15 2002 DNA AND CELL BIOLOGY 21(12):895-913
Lai CM; Lai YKY; Rakoczy PE Adenovirus and adeno-associated virus vectors | 0 | 7 |
| 16 | 1 | 69 | 16 2002 DRUG DISCOVERY TODAY 7(13):719-727
Polo JM; Dubensky TW Virus-based vectors for human vaccine applications | 2 | 5 |
| 17 | 2 | 158 | 17 2002 ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 20(10):511-522
Alcami J Present situation regarding development of an HIV vaccine | 0 | 0 |
| 18 | 1 | 252 | 18 2002 IMMUNOLOGICAL REVIEWS 185():236-265
Gallo RC Human retroviruses after 20 years: a perspective from the past and prospects for their future control | 0 | 5 |
| 19 | 1 | 176 | 19 2002 INTERNATIONAL JOURNAL OF ONCOLOGY 21(6):1161-1174
Bauerschmitz GJ; Barker SD; Hemminki A Adenoviral gene therapy for cancer: From vectors to targeted and replication competent agents (Review) | 0 | 8 |
| 20 | 2 | 27 | 20 2002 JOURNAL OF CLINICAL INVESTIGATION 110(1):15-20
Letvin NL Strategies for an HIV vaccine | 9 | 18 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 21 | 1 | 32 | 21 2002 JOURNAL OF CONTROLLED RELEASE 82(1):137-147
Berkland C; King M; Cox A; Kim K; Pack DW Precise control of PLG microsphere size provides enhanced control of drug release rate | 0 | 10 |
| 22 | 1 | 76 | 22 2002 JOURNAL OF IMMUNOLOGY 169(8):4172-4182
Messmer D; Jacque JM; Santisteban C; Bristow C; Hang SY; Villamide-Herrera L; Mehlhop E; Marx PA; Steinman RM; Gettie A; Pope M Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells | 1 | 15 |
| 23 | 1 | 54 | 23 2002 JOURNAL OF IMMUNOLOGY 169(9):4778-4787
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G Containment of simian immunodeficiency virus infection in vaccinated macaques: Correlation with the magnitude of virus-specific pre-and postchallenge CD4(+) and CD8(+) T cell responses | 5 | 11 |
| 24 | 2 | 39 | 24 2002 JOURNAL OF MEDICAL PRIMATOLOGY 31(4-5):179-185
Muthumani K; Bagarazzi M; Conway D; Hwang DS; Ayyavoo V; Zhang D; Manson K; Kim J; Boyer J; Weiner DB Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques | 0 | 1 |
| 25 | 2 | 85 | 25 2002 JOURNAL OF MEDICAL PRIMATOLOGY 31(4-5):237-256
Warren J Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates | 2 | 4 |
| 26 | 1 | 23 | 26 2002 JOURNAL OF VIROLOGY 76(12):6138-6146
Amara RR; Smith JM; Staprans SI; Montefiori DC; Villinger F; Altman JD; O'Neil SP; Kozyr NL; Xu Y; Wyatt LS; Earl PL; Herndon JG; McNicholl JM; McClure HM; Moss B; Robinson HL Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine | 17 | 22 |
| 27 | 2 | 48 | 27 2002 JOURNAL OF VIROLOGY 76(17):8690-8701
Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJR; Walker BD; Altfeld M Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8(+) T-cell responses following acute HIV-1 infection | 6 | 21 |
| 28 | 2 | 25 | 28 2002 JOURNAL OF VIROLOGY 76(19):10038-10043
Caulfield MJ; Wang S; Smith JG; Tobery TW; Liu X; Davies ME; Casimiro DR; Fu TM; Simon A; Evans RK; Emini EA; Shiver J Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus Gag DNA Vaccines | 3 | 9 |
| 29 | 3 | 27 | 29 2002 JOURNAL OF VIROLOGY 76(20):10147-10154
Tang YY; Villinger F; Staprans SI; Amara RR; Smith JM; Herndon JG; Robinson HL Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges | 1 | 3 |
| 30 | 2 | 101 | 30 2002 JOURNAL OF VIROLOGY 76(20):10155-10168
Novitsky V; Cao H; Rybak N; Gilbert P; McLane MF; Gaolekwe S; Peter T; Thior I; Ndung'u T; Marlink R; Lee TH; Essex M Magnitude and frequency of cytotoxic T-lymphocyte responses: Identification of immunodominant regions of human immunodeficiency virus type 1 subtype C | 4 | 12 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 31 | 1 | 41 | 31 2002 JOURNAL OF VIROLOGY 76(20):10507-10511
Allen TM; Jing PC; Calore B; Horton H; O'Connor DH; Hanke T; Piekarczyk M; Ruddersdorf R; Mothe BR; Emerson C; Wilson N; Lifson JD; Belyakov IM; Berzofsky JA; Wang CX; Allison DB; Montefiori DC; Desrosiers RC; Wolinsky S; Kunstman KJ; Altman JD; Sette A; McMichael AJ; Watkins DI Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection | 3 | 4 |
| 32 | 1 | 85 | 32 2002 JOURNAL OF VIROLOGY 76(22):11365-11378
Shacklett BL; Shaw KES; Adamson LA; Wilkens DT; Cox CA; Montefiori DC; Gardner MB; Sonigo P; Luciw PA Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251 | 0 | 1 |
| 33 | 1 | 30 | 33 2002 JOURNAL OF VIROLOGY 76(22):11484-11490
Baig J; Levy DB; McKay PF; Schmitz JE; Santra S; Subbramanian RA; Kuroda MJ; Lifton MA; Gorgone DA; Wyatt LS; Moss B; Huang Y; Chakrabarti BK; Xu L; Kong WP; Yang ZY; Mascola JR; Nabel GJ; Carville A; Lackner AA; Veazey RS; Letvin NL Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination | 3 | 5 |
| 34 | 1 | 51 | 34 2002 JOURNAL OF VIROLOGY 76(24):12735-12746
Himoudi N; Abraham JD; Fournillier A; Lone YC; Joubert A; De Beeck AO; Freida D; Lemonnier F; Kieny MP; Inchauspe G Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection | 0 | 2 |
| 35 | 1 | 37 | 35 2002 JOURNAL OF VIROLOGY 76(24):12845-12854
Zhang ZQ; Fu TM; Casimiro DR; Davies ME; Liang XP; Schleif WA; Handt L; Tussey L; Chen MC; Tang AM; Wilson KA; Trigona WL; Freed DC; Tan CY; Horton M; Emini EA; Shiver JW Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection | 4 | 6 |
| 36 | 3 | 4 | 36 2002 LANCET 359(9302):235-235
Senior K HIV-vaccine research takes one steps forward ... and one step back | 0 | 1 |
| 37 | 2 | 81 | 37 2002 LANCET 359(9325):2261-2267
Weidle PJ; Mastro TD; Grant AD; Nkengasong J; Macharia D HIV/AIDS treatment and HIV vaccines for Africa | 1 | 12 |
| 38 | 2 | 166 | 38 2002 LANCET INFECTIOUS DISEASES 2(6):353-367
Vandepapeliere P Therapeutic vaccination against chronic viral infections | 1 | 4 |
| 39 | 2 | 15 | 39 2002 NATURE 415(6869):272-273
Lifson JD; Martin MA AIDS vaccines - One step forwards, one step back | 7 | 12 |
| 40 | 0 | 20 | 40 2002 NATURE 415(6869):331-335
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang LY; Harris VA; Long RS; Liang XP; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen MC; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity | 183 | 183 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 41 | 1 | 27 | 41 2002 NATURE 415(6869):335-339
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes | 74 | 164 |
| 42 | 3 | 27 | 42 2002 NATURE 420(6914):434-439
Altfeld M; Allen TM; Yu XG; Johnston MN; Agrawal D; Korber BT; Montefiori DC; O'Connor DH; Davis BT; Lee PK; Maier EL; Harlow J; Goulder PJR; Brander C; Rosenberg ES; Walker BD HIV-1 superinfection despite broad CD8(+) T-cell responses containing replication of the primary virus | 6 | 42 |
| 43 | 2 | 35 | 43 2002 NATURE MEDICINE 8(3):207-210
Feinberg MB; Moore JP AIDS vaccine models: Challenging challenge viruses | 16 | 26 |
| 44 | 2 | 3 | 44 2002 NATURE REVIEWS IMMUNOLOGY 2(2):69-69
Bell E Keep right on to the end of the road... | 0 | 0 |
| 45 | 3 | 116 | 45 2002 NATURE REVIEWS IMMUNOLOGY 2(4):239-250
Robinson HL New hope for an AIDS vaccine | 17 | 35 |
| 46 | 2 | 126 | 46 2002 NATURE REVIEWS IMMUNOLOGY 2(4):283-291
McMichael A; Hanke T The quest for an AIDS vaccine: is the CD8(+) T-cell approach feasible? | 8 | 30 |
| 47 | 3 | 85 | 47 2002 NATURE REVIEWS IMMUNOLOGY 2(9):706-713
Burton DR Antibodies, viruses and vaccines | 3 | 46 |
| 48 | 3 | 28 | 48 2002 PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 269(1504):2035-2040
Kamp C; Bornholdt S From HIV infection to AIDS: a dynamically induced percolation transition? | 0 | 1 |
| 49 | 1 | 9 | 49 2002 REVUE DE MEDECINE INTERNE 23(8):679-682
Ardaillou R Gene therapy: present situation and prospects | 0 | 0 |
| 50 | 2 | 8 | 50 2002 SCIENTIST 16(18):28-29
Russo E Scientists combine two approaches to thwart the spread of HIV | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 51 | 2 | 63 | 51 2002 TRENDS IN IMMUNOLOGY 23(9):456-460
Allen TM; Kelleher AD; Zaunders J; Walker BD STI and beyond: the prospects of boosting anti-HIV immune responses | 0 | 7 |
| 52 | 4 | 51 | 52 2002 TRENDS IN MOLECULAR MEDICINE 8(10):489-495
Amara RR; Robinson HL A new generation of HIV vaccines | 1 | 4 |
| 53 | 2 | 15 | 53 2002 VACCINE 20():A66-A68
Barouch DH; Letvin NL Viral evolution and challenges in the development of HIV vaccines | 0 | 4 |
| 54 | 1 | 35 | 54 2002 VACCINE 20(27-28):3413-3421
Liang XP; Fu TM; Xie H; Emini EA; Shiver JW Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice | 2 | 3 |
| 55 | 1 | 52 | 55 2002 VACCINE 21(3-4):202-210
Arribillaga L; de Cerio ALD; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borras-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus | 1 | 4 |
| 56 | 1 | 47 | 56 2002 VIROLOGY 301(1):176-187
Dale CJ; Liu XSS; De Rose R; Purcell DFJ; Anderson J; Xu Y; Leggatt GR; Frazer IH; Kent SJ Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: Immunogenicity and protective efficacy in macaques | 0 | 2 |
| 57 | 1 | 161 | 57 2003 ADENOVIRUSES: MODEL AND VECTORS IN VIRUS-HOST INTERACTIONS 272():57-94
Martin CS; Burnett RM Structural studies on adenoviruses | 0 | 0 |
| 58 | 2 | 15 | 58 2003 AIDS PATIENT CARE AND STDS 17(2):47-51
Johnston R AIDSVAX results: An answer, or just more questions? | 1 | 1 |
| 59 | 2 | 71 | 59 2003 BIOMEDICINE & PHARMACOTHERAPY 57(1):4-14
Richardson MW; Mirchandani J; Duong J; Grimaldo S; Kocieda V; Hendel H; Khalili K; Zagury JF; Rappaport J Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection | 0 | 3 |
| 60 | 2 | 28 | 60 2003 BIOMETRICS 59(3):531-541
Gilbert PB; Bosch RJ; Hudgens MG Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials | 0 | 2 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 61 | 1 | 37 | 61 2003 BLOOD 102(1):223-228
Xin KQ; Hoshino Y; Toda Y; Igimi S; Kojima Y; Jounai N; Ohba K; Kushiro A; Kiwaki M; Hamajima K; Klinman D; Okuda K Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env | 0 | 2 |
| 62 | 2 | 44 | 62 2003 CLINICAL INFECTIOUS DISEASES 36(5):638-644
Hu DJ; Vitek CR; Bartholow B; Mastro TD Key issues for a potential human immunodeficiency virus vaccine | 0 | 2 |
| 63 | 3 | 31 | 63 2003 CLINICAL MEDICINE 3(3):269-272
McMichael A Prospects for an AIDS vaccine | 0 | 1 |
| 64 | 1 | 52 | 64 2003 COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES 26(5-6):329-341
Leclerc C New approaches in vaccine development | 0 | 0 |
| 65 | 3 | 55 | 65 2003 COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES 26(5-6):357-372
Puaux AL; Michel ML New gene-based approaches for an AIDS vaccine | 0 | 0 |
| 66 | 8 | 177 | 66 2003 CURRENT HIV RESEARCH 1(1):101-120
Spearman P HIV vaccine development: Lessons from the past and promise for the future | 1 | 4 |
| 67 | 1 | 81 | 67 2003 CURRENT HIV RESEARCH 1(2):229-237
McKenna PM; McGettigan JP; Pomerantz RJ; Dietzschold B; Schnell MJ Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases | 1 | 2 |
| 68 | 4 | 118 | 68 2003 CURRENT MOLECULAR MEDICINE 3(3):183-193
Esparza J; Osmanov S HIV vaccines: A global perspective | 1 | 3 |
| 69 | 2 | 194 | 69 2003 CURRENT MOLECULAR MEDICINE 3(3):195-208
Kalams SA Cellular immunity for prevention and clearance of HIV infection | 0 | 0 |
| 70 | 2 | 217 | 70 2003 CURRENT MOLECULAR MEDICINE 3(3):243-263
Cho MW Subunit protein vaccines: Theoretical and practical considerations for HIV-1 | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 71 | 2 | 142 | 71 2003 CURRENT MOLECULAR MEDICINE 3(3):273-284
Voltan R; Robert-Guroff M Live recombinant vectors for AIDS vaccine development | 1 | 3 |
| 72 | 5 | 206 | 72 2003 CURRENT MOLECULAR MEDICINE 3(3):285-301
Ahlers JD; Belyakov IM; Berzofsky JA Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines | 0 | 4 |
| 73 | 1 | 204 | 73 2003 CURRENT TOPICS IN MEDICINAL CHEMISTRY 3(13):1536-1553
Gilliam BL; Redfield RR Therapeutic HIV vaccines | 1 | 2 |
| 74 | 2 | 126 | 74 2003 DENDRITIC CELLS AND VIRUS INFECTION 276():1-30
Steinman RM; Granelli-Piperno A; Pope M; Trumpfheller C; Ignatius R; Arrode G; Racz P; Tenner-Racz K The interaction of immunodeficiency viruses with dendritic cells | 0 | 5 |
| 75 | 1 | 60 | 75 2003 DNA AND CELL BIOLOGY 22(6):421-430
Robinson TM; Nelson RG; Boyer JD Parasitic infection and the polarized Th2 immune response can alter a vaccine-induced immune response | 0 | 0 |
| 76 | 1 | 152 | 76 2003 ENZYME AND MICROBIAL TECHNOLOGY 33(7):865-883
Prather KJ; Sagar S; Murphy J; Chartrain M Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification | 0 | 0 |
| 77 | 1 | 33 | 77 2003 EUROPEAN JOURNAL OF BIOCHEMISTRY 270(10):2287-2294
Richards JL; Abend JR; Miller ML; Chakraborty-Sett S; Dewhurst S; Whetter LE A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells | 0 | 1 |
| 78 | 2 | 75 | 78 2003 FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 37(2-3):129-134
Fouts TR; DeVico AL; Onyabe DY; Shata MT; Bagley KC; Lewis GK; Hone DM Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1 | 0 | 1 |
| 79 | 1 | 65 | 79 2003 GENE THERAPY 10(4):326-336
Nan X; Peng B; Hahn TW; Richardson E; Lizonova A; Kovesdi I; Robert-Guroff M Development of an Ad7 cosmid system and generation of an Ad7 Delta E1 Delta E3HIV(MN) env/rev recombinant virus | 1 | 1 |
| 80 | 1 | 22 | 80 2003 HUMAN GENE THERAPY 14(1):25-36
Wang FB; Patel DK; Antonello JM; Washabaugh MW; Kaslow DC; Shiver JW; Chirmule N Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens | 1 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 81 | 4 | 71 | 81 2003 HUMAN GENE THERAPY 14(17):1673-1682
Tan YD; Hackett NR; Boyer JL; Crystal RG Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen | 0 | 0 |
| 82 | 1 | 39 | 82 2003 IMMUNOLOGY 108(4):548-555
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; De Lisle GW; Buddle BM A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis | 0 | 2 |
| 83 | 1 | 22 | 83 2003 IMMUNOLOGY LETTERS 85(2):215-222
Otten GR; Chen MC; Doe B; zur Megede J; Barnett S; Ulmer J Quantitative assessment of antigen-specific CD8+T cells in the mouse: application to vaccine research | 0 | 0 |
| 84 | 3 | 34 | 84 2003 IMMUNOLOGY LETTERS 89(2-3):207-214
Majumder B; Gray B; McBurney S; Schaefer TM; Dentchev T; Mahalingam S; Reinhart TA; Ayyavoo V Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine | 0 | 0 |
| 85 | 2 | 13 | 85 2003 IMMUNOLOGY LETTERS 90(2-3):67-70
Locher CP; Putnam D; Langer R; Witt SA; Ashlock BM; Levy JA Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation | 0 | 0 |
| 86 | 4 | 74 | 86 2003 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 33(4):426-438
Sabbaj S; Bansal A; Ritter GD; Perkins C; Edwards BH; Gough E; Tang JM; Szinger JJ; Korber B; Wilson CM; Kaslow RA; Mulligan MJ; Goepfert PA Cross-reactive CD8(+) T cell epitopes identified in US adolescent minorities | 1 | 1 |
| 87 | 3 | 38 | 87 2003 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 34(2):214-220
van Ballegooijen M; Bogaards JA; Weverling GJ; Boerlijst MC; Goudsmit J AIDS vaccines that allow HIV-1 to infect and escape immunologic control - A mathematic analysis of mass vaccination | 0 | 0 |
| 88 | 1 | 23 | 88 2003 JOURNAL OF CLINICAL MICROBIOLOGY 41(11):5046-5052
Sprangers MC; Lakhai W; Koudstaal W; Verhoeven M; Koel BF; Vogels R; Goudsmit J; Havenga MJE; Kostense S Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors | 1 | 2 |
| 89 | 2 | 117 | 89 2003 JOURNAL OF GENE MEDICINE 5(1):3-10
Mwau M; McMichael AJ A review of vaccines for HIV prevention | 1 | 4 |
| 90 | 1 | 64 | 90 2003 JOURNAL OF GENERAL VIROLOGY 84():203-213
Vinner L; Wee EGT; Patel S; Corbet S; Gao GP; Nielsen C; Wilson JM; Ertl HCJ; Hanke T; Fomsgaard A Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost | 4 | 4 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 91 | 1 | 27 | 91 2003 JOURNAL OF IMMUNOLOGY 170(3):1416-1422
Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HCJ A simian replication-defective vaccine to HIV-1 gag | 5 | 5 |
| 92 | 1 | 82 | 92 2003 JOURNAL OF IMMUNOLOGY 170(7):3906-3914
Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou JT; Johnston MN; Gao F; Walker BD; Rosenberg ES Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual | 0 | 4 |
| 93 | 2 | 65 | 93 2003 JOURNAL OF IMMUNOLOGY 171(5):2538-2547
Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses | 1 | 4 |
| 94 | 1 | 53 | 94 2003 JOURNAL OF IMMUNOLOGY 171(9):4717-4725
Wang XH; Hone DM; Haddad A; Shata MT; Pascual DW M cell DNA vaccination for CTL immunity to HIV | 0 | 2 |
| 95 | 4 | 93 | 95 2003 JOURNAL OF IMMUNOLOGY 171(10):5611-5623
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1 | 0 | 0 |
| 96 | 6 | 31 | 96 2003 JOURNAL OF IMMUNOLOGY 171(12):6774-6779
Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HCJ Induction of CD8(+) T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers | 1 | 1 |
| 97 | 1 | 27 | 97 2003 JOURNAL OF INFECTIOUS DISEASES 187(6):887-895
Cao H; Kaleebu P; Hom D; Flores J; Agrawal D; Jones N; Serwanga J; Okello M; Walker C; Sheppard H; El-Habib R; Klein M; Mbidde E; Mugyenyi P; Walker B; Ellner J; Mugerwa R Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-Seronegative Ugandan volunteers: Results of the HIV Network for Prevention Trials 007 vaccine study | 2 | 6 |
| 98 | 2 | 97 | 98 2003 JOURNAL OF INFECTIOUS DISEASES 187(9):1349-1359
Plotkin SA Vaccines, vaccination, and vaccinology | 0 | 0 |
| 99 | 2 | 88 | 99 2003 JOURNAL OF INFECTIOUS DISEASES 188(2):179-193
Gilbert PB; DeGruttola VG; Hudgens MG; Self SG; Hammer SM; Corey L What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: Issues involving surrogate end points in phase 3 trials | 0 | 1 |
| 100 | 3 | 35 | 100 2003 JOURNAL OF MEDICAL PRIMATOLOGY 32(4-5):218-228
Doria-Rose NA; Pierce CC; Hensel MT; Sutton WF; Sheikh N; Polacino P; Kuller L; Zhu YD; Hu SL; Anderson D; Haigwood NL Multigene DNA prime-boost vaccines for SHIV89.6P | 1 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 101 | 1 | 30 | 101 2003 JOURNAL OF VIROLOGY 77(1):799-803
Yang ZY; Wyatt LS; Kong WP; Moodie Z; Moss B; Nabel GJ Overcoming immunity to a viral vaccine by DNA priming before vector boosting | 8 | 16 |
| 102 | 2 | 70 | 102 2003 JOURNAL OF VIROLOGY 77(2):882-890
Novitsky V; Gilbert P; Peter T; McLane MF; Gaolekwe S; Rybak N; Thior I; Ndung'u T; Marlink R; Lee TH; Essex M Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection | 2 | 5 |
| 103 | 3 | 82 | 103 2003 JOURNAL OF VIROLOGY 77(2):1049-1058
Voss G; Manson K; Montefiori D; Watkins DI; Heeney J; Wyand M; Cohen J; Bruck C Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine | 1 | 3 |
| 104 | 2 | 83 | 104 2003 JOURNAL OF VIROLOGY 77(2):1163-1174
Willey RL; Byrum R; Piatak M; Kim YB; Cho MW; Rossio JL; Bess J; Igarashi T; Endo Y; Arthur LO; Lifson JD; Martin MA Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles | 5 | 12 |
| 105 | 3 | 51 | 105 2003 JOURNAL OF VIROLOGY 77(3):2081-2092
Addo MM; Yu XG; Rathod A; Cohen D; Eldridge RL; Strick D; Johnston MN; Corcoran C; Wurcel AG; Fitzpatrick CA; Feeney ME; Rodriguez WR; Basgoz N; Draenert R; Stone DR; Brander C; Goulder PJR; Rosenberg ES; Altfeld M; Walker BD Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load | 7 | 36 |
| 106 | 1 | 43 | 106 2003 JOURNAL OF VIROLOGY 77(4):2400-2409
Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galan JE; Johnson PR Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system | 2 | 6 |
| 107 | 1 | 30 | 107 2003 JOURNAL OF VIROLOGY 77(8):4695-4702
McKay PF; Barouch DH; Schmitz JE; Veazey RS; Gorgone DA; Lifton MA; Williams KC; Letvin NL Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination | 4 | 5 |
| 108 | 1 | 40 | 108 2003 JOURNAL OF VIROLOGY 77(10):6087-6092
Otten G; Schaefer M; Greer C; Calderon-Cacia M; Coit D; Kazzaz J; Medina-Selby A; Selby M; Singh M; Ugozzoli M; zur Megede J; Barnett SW; O'Hagan D; Donnelly J; Ulmer J Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles | 1 | 7 |
| 109 | 3 | 57 | 109 2003 JOURNAL OF VIROLOGY 77(11):6197-6207
Megede JZ; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA Vaccines | 0 | 0 |
| 110 | 3 | 29 | 110 2003 JOURNAL OF VIROLOGY 77(11):6305-6313
Casimiro DR; Chen L; Fu TM; Evans RK; Caulfield MJ; Davies ME; Tang A; Chen MC; Huang LY; Harris V; Freed DC; Wilson KA; Dubey S; Zhu DM; Nawrocki D; Mach H; Troutman R; Isopi L; Williams D; Hurni W; Xu Z; Smith JG; Wang S; Liu X; Guan LM; Long R; Trigona W; Heidecker GJ; Perry HC; Persaud N; Toner TJ; Su Q; Liang XP; Youil R; Chastain M; Bell AJ; Volkin DB; Emini EA; Shiver JW Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene | 9 | 12 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 111 | 3 | 31 | 111 2003 JOURNAL OF VIROLOGY 77(13):7367-7375
Barouch DH; Kunstman J; Glowczwskie J; Kunstman KJ; Egan MA; Peyerl FW; Santra S; Kuroda MJ; Schmitz JE; Beaudry K; Krivulka GR; Lifton MA; Gorgone DA; Wolinsky SM; Letvin NL Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys | 2 | 7 |
| 112 | 4 | 29 | 112 2003 JOURNAL OF VIROLOGY 77(13):7663-7668
Casimiro DR; Tang AM; Chen L; Fu TM; Evans RK; Davies ME; Freed DC; Hurni W; Aste-Amezaga JM; Guan LM; Long R; Huang LY; Harris V; Nawrocki DK; Mach H; Troutman RD; Isopi LA; Murthy KK; Rice K; Wilson KA; Volkin DB; Emini EA; Shiver JW Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene | 1 | 1 |
| 113 | 1 | 58 | 113 2003 JOURNAL OF VIROLOGY 77(15):8263-8271
Vogels R; Zuijdgeest D; van Rijnsoever R; Hartkoorn E; Damen I; de Bethune MP; Kostense S; Penders G; Helmus N; Koudstaal W; Cecchini M; Wetterwald A; Sprangers M; Lemckert A; Ophorst O; Koel B; van Meerendonk M; Quax P; Panitti L; Grimbergen J; Bout A; Goudsmit J; Havenga M Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: Efficient human cell infection and bypass of preexisting adenovirus immunity | 2 | 6 |
| 114 | 3 | 55 | 114 2003 JOURNAL OF VIROLOGY 77(15):8354-8365
Zhao J; Pinczewski J; Gomez-Roman VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou YM; Pavlakis GN; Robert-Guroff M Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIVmac251 challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen | 3 | 3 |
| 115 | 6 | 66 | 115 2003 JOURNAL OF VIROLOGY 77(16):8607-8620
Patterson LJ; Malkevitch N; Pinczewski J; Venzon D; Lou YM; Peng B; Munch C; Leonard M; Richardson E; Aldrich K; Kalyanaraman VS; Pavlakis GN; Robert-Guroff M Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120 | 2 | 2 |
| 116 | 2 | 24 | 116 2003 JOURNAL OF VIROLOGY 77(16):8729-8735
Barouch DH; McKay PF; Sumida SM; Santra S; Jackson SS; Gorgone DA; Lifton MA; Chakrabarti BK; Xu L; Nabel GJ; Letvin NL Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines | 3 | 5 |
| 117 | 1 | 26 | 117 2003 JOURNAL OF VIROLOGY 77(17):9710-9715
Takeda A; Igarashi H; Nakamura H; Kano M; Iida A; Hirata T; Hasegawa M; Nagai Y; Matano T Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model | 1 | 1 |
| 118 | 3 | 33 | 118 2003 JOURNAL OF VIROLOGY 77(19):10348-10356
Mascola JR; Lewis MG; VanCott TC; Stiegler G; Katinger H; Seaman M; Beaudry K; Barouch DH; Korioth-Schmitz B; Krivulka G; Sambor A; Welcher B; Douek DC; Montefiori DC; Shiver JW; Poignard P; Burton DR; Letvin NL Cellular immunity elicited by human immunodeficiency virus type 1/simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies | 1 | 3 |
| 119 | 1 | 33 | 119 2003 JOURNAL OF VIROLOGY 77(20):10780-10789
Xiang ZQ; Gao GP; Reyes-Sandoval A; Li Y; Wilson JM; Ertl HCJ Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier | 0 | 0 |
| 120 | 4 | 52 | 120 2003 JOURNAL OF VIROLOGY 77(20):10829-10840
Igarashi T; Endo Y; Nishimura Y; Buckler C; Sadjadpour R; Donau OK; Dumaurier MJ; Plishka RJ; Buckler-White A; Martin MA Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes | 1 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 121 | 6 | 57 | 121 2003 JOURNAL OF VIROLOGY 77(20):10889-10899
McGettigan JP; Naper K; Orenstein J; Koser M; McKenna PM; Schnell MJ Functional human immunodeficiency virus type 1 (HIV-1) gag-pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome | 0 | 0 |
| 122 | 10 | 73 | 122 2003 JOURNAL OF VIROLOGY 77(21):11563-11577
Doria-Rose NA; Ohlen C; Polacino P; Pierce CC; Hensel MT; Kuller L; Mulvania T; Anderson D; Greenberg PD; Hu SL; Haigwood NL Multigene DNA priming-boosting vaccines protect macaques from acute CD4(+)-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge | 1 | 1 |
| 123 | 4 | 53 | 123 2003 JOURNAL OF VIROLOGY 77(23):12430-12440
Geels MJ; Cornelissen M; Schuitemaker H; Anderson K; Kwa D; Maas J; Dekker JT; Baan E; Zorgdrager F; van den Burg R; van Beelen M; Lukashov VV; Fu TM; Paxton WA; van der Hoek L; Dubey SA; Shiver JW; Goudsmit J Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual | 0 | 1 |
| 124 | 3 | 41 | 124 2003 JOURNAL OF VIROLOGY 77(23):12764-12772
Kong WP; Huang Y; Yang ZY; Chakrabarti BK; Moodie Z; Nabel GJ Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA Vaccines | 0 | 1 |
| 125 | 4 | 46 | 125 2003 JOURNAL OF VIROLOGY 77(23):12907-12913
Jaiswal S; Khanna N; Swaminathan S Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2 | 0 | 0 |
| 126 | 1 | 48 | 126 2003 JOURNAL OF VIROLOGY 77(24):13248-13256
Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys | 0 | 0 |
| 127 | 3 | 55 | 127 2003 JOURNAL OF VIROLOGY 77(24):13348-13360
Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang CX; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239 | 0 | 0 |
| 128 | 1 | 22 | 128 2003 JOURNAL OF VIROLOGY 77(24):13407-13411
Yang TC; Dayball K; Wan YH; Bramson J Detailed analysis of the CD8(+) T-Cell response following adenovirus vaccination | 0 | 1 |
| 129 | 2 | 109 | 129 2003 METHODS 31(3):207-216
Doria-Rose NA; Haigwood NL DNA vaccine strategies: candidates for immune modulation and immunization regimens | 0 | 0 |
| 130 | 2 | 9 | 130 2003 NATURE MEDICINE 9(6):642-643
Robinson HL Prime boost vaccines power up in people | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 131 | 5 | 106 | 131 2003 NATURE MEDICINE 9(7):861-866
Letvin NL; Walker BD Immunopathogenesis and immunotherapy in AIDS virus infections | 0 | 11 |
| 132 | 5 | 112 | 132 2003 NATURE MEDICINE 9(7):874-880
McMichael AJ; Hanke T HIV vaccines 1983-2003 | 1 | 17 |
| 133 | 5 | 59 | 133 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(25):15131-15136
Nishimura Y; Igarashi T; Haigwood NL; Sadjadpour R; Donau OK; Buckler C; Plishka RJ; Buckler-White A; Martin MA Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development | 0 | 1 |
| 134 | 3 | 101 | 134 2003 VACCINE 21():S68-S76
Lehner T Innate and adaptive mucosal immunity in protection against HIV infection | 0 | 2 |
| 135 | 1 | 116 | 135 2003 VACCINE 21(5-6):419-430
Esser MT; Marchese RD; Kierstead LS; Tussey LG; Wang FB; Chirmule N; Washabaugh MW Memory T cells and vaccines | 0 | 4 |
| 136 | 3 | 31 | 136 2003 VACCINE 21(7-8):616-619
Klein M Prospects and challenges for prophylactic and therapeutic HIV vaccines | 1 | 2 |
| 137 | 3 | 25 | 137 2003 VACCINE 21(7-8):629-637
Muthumani K; Bagarazzi M; Conway D; Hwang DS; Manson K; Ciccarelli R; Israel Z; Montefiori DC; Ugen K; Miller N; Kim J; Boyer J; Weiner DB A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in Rhesus Macaques | 2 | 2 |
| 138 | 3 | 29 | 138 2003 VACCINE 21(19-20):2288-2297
Wang XQ; Wiley RD; Evans TG; Bowers WJ; Federoff HJ; Dewhurst S Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming | 0 | 0 |
| 139 | 2 | 57 | 139 2003 VACCINE 21(25-26):4022-4035
Zhao J; Lou YM; Pinczewski J; Malkevitch N; Aldrich K; Kalyanaraman VS; Venzon D; Peng B; Patterson LJ; Edghill-Smith Y; Woodward R; Pavlakis GN; Robert-Guroff M Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants | 2 | 2 |
| 140 | 2 | 43 | 140 2003 VIRAL IMMUNOLOGY 16(4):525-539
Wang XH; Hillemeyer P; Pascual DW Segregation of mechanisms for cytotoxic T lymphocyte killing between lungs and regional lymph nodes subsequent to intratracheal delivery of adenovirus 2 vector | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 141 | 2 | 36 | 141 2003 VIROLOGY 306(1):116-125
Cheevers WP; Snekvik KR; Trujillo JD; Kumpula-McWhirter NMK; Top KJPO; Knowles DP Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis | 0 | 0 |
| 142 | 2 | 56 | 142 2003 VIROLOGY 309(2):272-281
Bu ZG; Ye L; Compans RW; Yang CL Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins | 0 | 0 |
| 143 | 2 | 72 | 143 2003 VIROLOGY 315(2):425-437
Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease | 0 | 0 |
| 144 | 3 | 62 | 144 2004 ADVANCED DRUG DELIVERY REVIEWS 56(6):835-852
Crotty S; Andino R Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine | 0 | 0 |
| 145 | 4 | 50 | 145 2004 AIDS 18(1):25-36
Bogers WMJM; Bergmeier LA; Ma J; Oostermeijer H; Wang YF; Kelly CG; ten Haaft P; Singh M; Heeney JL; Lehner T A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection | 0 | 0 |
| 146 | 8 | 54 | 146 2004 AIDS RESEARCH AND HUMAN RETROVIRUSES 20(2):235-244
Malkevitch N; Rohne D; Pinczewski J; Aldrich K; Kalyanaraman VS; Letvin NL; Robert-Guroff M Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques | 0 | 0 |
| 147 | 2 | 32 | 147 2004 AIDS RESEARCH AND HUMAN RETROVIRUSES 20(4):425-434
Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles | 0 | 0 |
| 148 | 1 | 16 | 148 2004 BIOTECHNOLOGY PROGRESS 20(2):443-448
Gao WT; Rzewski A; Sun HJ; Robbins PD; Gambotto A UpGene: Application of a web-based DNA codon optimization algorithm | 0 | 0 |
| 149 | 1 | 38 | 149 2004 CANCER RESEARCH 64(4):1483-1489
Duraiswamy J; Bharadwaj M; Tellam J; Connolly G; Cooper L; Moss D; Thomson S; Yotnda P; Khanna R Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine | 0 | 0 |
| 150 | 12 | 219 | 150 2004 CLINICAL MICROBIOLOGY REVIEWS 17(2):370-+
Giri M; Ugen KE; Weiner DB DNA vaccines against human immunodeficiency virus type 1 in the past decade | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 151 | 1 | 235 | 151 2004 CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 41(1):1-39
Manoj S; Babiuk LA; Littel-van den Hurk SV Approaches to enhance the efficacy of DNA vaccines | 0 | 0 |
| 152 | 2 | 166 | 152 2004 CURRENT DRUG TARGETS 5(1):41-56
Torresi J; Bharadwaj M; Jackson DC; Gowan EJ Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: A preventative vaccine strategy | 0 | 0 |
| 153 | 6 | 114 | 153 2004 CURRENT DRUG TARGETS 5(1):71-88
Stratov I; DeRose R; Purcell DFJ; Kent SJ Vaccines and vaccine strategies against HIV | 0 | 0 |
| 154 | 5 | 105 | 154 2004 CURRENT HIV RESEARCH 2(2):193-204
McGaughey GB; Barbato G; Bianchi E; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang XP; Miller MD; Pessi A; Shiver JW; Bogusky MJ Progress towards the development of a HIV-1 gp41-directed vaccine | 0 | 0 |
| 155 | 3 | 49 | 155 2004 HUMAN GENE THERAPY 15(3):293-304
Aste-Amezaga M; Bett AJ; Wang FB; Casimiro DR; Antonello JM; Patel DK; Dell EC; Franlin LL; Dougherty NM; Bennett PS; Perry HC; Davies ME; Shiver JW; Keller PM; Yeager MD Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: Application in epidemiologic studies and in the design of adenovector vaccines | 0 | 0 |
| 156 | 3 | 104 | 156 2004 IMMUNOLOGICAL REVIEWS 199(1):126-143
Moore AC; Hill AVS Progress in DNA-based heterologous prime-boost immunization strategies for malaria | 0 | 0 |
| 157 | 4 | 30 | 157 2004 JOURNAL OF GENERAL VIROLOGY 85():409-413
Jaffray A; Shephard E; van Harmelen J; Williamson C; Williamson AL; Rybicki EP Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice | 0 | 0 |
| 158 | 6 | 44 | 158 2004 JOURNAL OF GENERAL VIROLOGY 85():1191-1201
Negri DRM; Baroncelli S; Catone S; Comini A; Michelini Z; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Boros S; Lijestrom P; Norley S; Heeney J; Titti F Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge | 0 | 0 |
| 159 | 1 | 46 | 159 2004 JOURNAL OF GENERAL VIROLOGY 85():1227-1236
Mercier S; Verhaagh S; Goudsmit J; Lemckert A; Monteil M; Havenga M; Eloit M Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8(+) immune responses in vivo | 0 | 0 |
| 160 | 4 | 79 | 160 2004 JOURNAL OF IMMUNOLOGY 172(6):3745-3757
Bertley FMN; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 161 | 8 | 33 | 161 2004 JOURNAL OF IMMUNOLOGY 172(10):6290-6297
Barouch DH; Pau MG; Custers JHHV; Koudstaal W; Kostense S; Havenga MJE; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity | 0 | 0 |
| 162 | 2 | 57 | 162 2004 JOURNAL OF VIROLOGY 78(1):116-123
Brandsma JL; Shlyankevich M; Zhang LX; Slade MD; Goodwin EC; Peh W; Deisseroth AB Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection | 0 | 0 |
| 163 | 2 | 84 | 163 2004 JOURNAL OF VIROLOGY 78(1):146-157
Lorin C; Mollet L; Delebecque F; Combredet C; Hurtrel B; Charneau P; Brahic M; Tangy F A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV | 0 | 0 |
| 164 | 1 | 31 | 164 2004 JOURNAL OF VIROLOGY 78(1):206-215
Seaman MS; Peyerl FW; Jackson SS; Lifton MA; Gorgone DA; Schmitz JE; Letvin NL Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo | 0 | 1 |
| 165 | 1 | 45 | 165 2004 JOURNAL OF VIROLOGY 78(3):1080-1092
Blancou P; Chenciner N; Fang RHT; Monceaux V; Cumont MC; Guetard D; Hurtrel B; Wain-Hobson S Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus | 0 | 0 |
| 166 | 7 | 55 | 166 2004 JOURNAL OF VIROLOGY 78(5):2187-2200
Frahm N; Korber BT; Adams CM; Szinger JJ; Draenert R; Addo MM; Feeney ME; Yusim K; Sango K; Brown NV; SenGupta D; Piechocka-Trocha A; Simonis T; Marincola FM; Wurcel AG; Stone DR; Russell CJ; Adolf P; Cohen D; Roach T; StJohn A; Khatri A; Davis K; Mullins J; Goulder PJR; Walker BD; Brander C Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities | 0 | 0 |
| 167 | 8 | 46 | 167 2004 JOURNAL OF VIROLOGY 78(5):2212-2221
Patterson LJ; Malkevitch N; Venzon D; Pinczewski J; Gomez-Roman VR; Wang LQ; Kalyanaraman VS; Markham PD; Robey FA; Robert-Guroff M Protection against mucosal simian immunodeficiency virus SIVmac251 challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting | 0 | 0 |
| 168 | 1 | 50 | 168 2004 JOURNAL OF VIROLOGY 78(5):2572-2580
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses | 0 | 0 |
| 169 | 6 | 32 | 169 2004 JOURNAL OF VIROLOGY 78(6):2666-2673
Sumida SM; Truitt DM; Kishko MG; Arthur JC; Jackson SS; Gorgone DA; Lifton MA; Koudstaal W; Pau MG; Kostense S; Havenga MJE; Goudsmit J; Letvin NL; Barouch DH Neutralizing antibodies and CD8(+) T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors | 0 | 0 |
| 170 | 4 | 31 | 170 2004 JOURNAL OF VIROLOGY 78(6):3140-3144
McDermott AB; Mitchen J; Piaskowski S; De Souza I; Yant LJ; Stephany J; Furlott J; Watkins DI Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 171 | 3 | 51 | 171 2004 JOURNAL OF VIROLOGY 78(7):3233-3243
Masemola A; Mashishi T; Khoury G; Mohube P; Mokgotho P; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8(+) T cells: Correlation with viral load | 0 | 0 |
| 172 | 6 | 70 | 172 2004 JOURNAL OF VIROLOGY 78(7):3333-3342
Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WMJM; ten Haaft PJF; Niphuis H; Koornstra W; Bieler K; Kostler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection | 0 | 0 |
| 173 | 4 | 29 | 173 2004 JOURNAL OF VIROLOGY 78(8):3930-3940
Ramsburg E; Rose NF; Marx PA; Mefford M; Nixon DF; Moretto WJ; Montefiori D; Earl P; Moss B; Rose JK Highly effective control of an AIDS virus challenge in macaques by using vesicular stornatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol | 0 | 0 |
| 174 | 3 | 26 | 174 2004 JOURNAL OF VIROLOGY 78(10):5513-5519
Sadjadpour R; Theodore TS; Igarashi T; Donau OK; Plishka RJ; Buckler-White A; Martin MA Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic | 0 | 0 |
| 175 | 3 | 19 | 175 2004 NATURE MEDICINE 10(3):221-223
Desrosiers RC Prospects for an AIDS vaccine | 0 | 0 |
| 176 | 1 | 50 | 176 2004 TRENDS IN IMMUNOLOGY 25(2):92-97
Moron G; Dadaglio G; Leclerc C New tools for antigen delivery to the MHC class I pathway | 0 | 0 |
| 177 | 4 | 88 | 177 2004 TRENDS IN IMMUNOLOGY 25(2):98-104
Woodland DL Jump-starting the immune system: prime-boosting comes of age | 0 | 0 |
| 178 | 3 | 25 | 178 2004 VACCINE 22(5-6):697-703
Pinto AR; Fitzgerald JC; Gao GP; Wilson JM; Ertl HCJ Induction of CD8(+) T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector | 0 | 0 |
| 179 | 1 | 25 | 179 2004 VACCINE 22(5-6):704-713
de Bruyn G; Rossini AJ; Chiu YL; Holman D; Elizaga ML; Frey SE; Burke D; Evans TG; Corey L; Keefer MC Safety profile of recombinant canarypox HIV vaccines | 0 | 0 |
| 180 | 3 | 34 | 180 2004 VACCINE 22(13-14):1764-1772
Liu FJ; Mboudjeka I; Shen SY; Chou THW; Wang SX; Ross TM; Lu S Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 181 | 1 | 24 | 181 2004 VACCINE 22(13-14):1791-1798
Zuber AK; Brave A; Engstrom G; Zuber B; Ljungberg K; Fredriksson M; Benthin R; Isaguliants MG; Sandstrom E; Hinkula J; Wahren B Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA | 0 | 0 |
| 182 | 3 | 54 | 182 2004 VIROLOGY 319(1):118-130
Ellenberger D; Li B; Smith J; Yi H; Folks T; Robinson H; Butera S Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms | 0 | 0 |
| 183 | 5 | 40 | 183 2004 VIROLOGY 320(1):75-84
Zhang ZQ; Schleif WA; Casimiro DR; Handt L; Chen MC; Davies ME; Liang XP; Fu TM; Tang AM; Wilson KA; McElhaugh M; Carella A; Tan C; Connolly B; Hill S; Klein H; Emini EA; Shiver JW The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P | 0 | 0 |
| 184 | 5 | 52 | 184 2004 VIROLOGY 320(1):167-180
Buckner C; Gines LG; Saunders CJ; Vojtech L; Srivastava I; Gettie A; Bohm R; Blanchard J; Barnett SW; Safrit JT; Stamatatos L Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV | 0 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.05.14